ATTENDS HEALTHCARE LIMITED

Company Registration Number:
06302122 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2024

Period of accounts

Start date: 1 January 2024

End date: 31 December 2024

ATTENDS HEALTHCARE LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2024

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

ATTENDS HEALTHCARE LIMITED

Directors' report period ended 31 December 2024

The directors present their report with the financial statements of the company for the period ended 31 December 2024

Principal activities of the company

The principal activity of the Company is that of a holding company



Directors

The directors shown below have held office during the whole of the period from
1 January 2024 to 31 December 2024

Sarah Curtis
Marcy Lemieux


Secretary Alessandra Salvo

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
26 September 2025

And signed on behalf of the board by:
Name: Sarah Curtis
Status: Director

ATTENDS HEALTHCARE LIMITED

Profit And Loss Account

for the Period Ended 31 December 2024

2024 2023


£

£
Administrative expenses: ( 10,000 ) ( 4,000 )
Operating profit(or loss): (10,000) (4,000)
Interest receivable and similar income: 2,000
Interest payable and similar charges: ( 13,000 )
Profit(or loss) before tax: (21,000) (4,000)
Profit(or loss) for the financial year: (21,000) (4,000)

ATTENDS HEALTHCARE LIMITED

Balance sheet

As at 31 December 2024

Notes 2024 2023


£

£
Current assets
Debtors: 3 41,000 38,000
Total current assets: 41,000 38,000
Creditors: amounts falling due within one year: 4 ( 259,000 ) ( 235,000 )
Net current assets (liabilities): (218,000) (197,000)
Total assets less current liabilities: (218,000) ( 197,000)
Total net assets (liabilities): (218,000) (197,000)
Capital and reserves
Called up share capital: 103,000 103,000
Share premium account: 888,000 888,000
Profit and loss account: (1,209,000 ) (1,188,000 )
Total Shareholders' funds: ( 218,000 ) (197,000)

The notes form part of these financial statements

ATTENDS HEALTHCARE LIMITED

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 26 September 2025
and signed on behalf of the board by:

Name: Sarah Curtis
Status: Director

The notes form part of these financial statements

ATTENDS HEALTHCARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Tangible fixed assets depreciation policy

    Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses. Depreciation is provided on all tangible fixed assets, at rates calculated to write-off the cost or valuation, less estimated residual value, of each asset evenly over its expected useful economic life, as follows: Computer systems 3 years The carrying values of tangible fixed assets are reviewed for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.

    Other accounting policies

    Exemptions for qualifying entities The Company has taken advantage of the following disclosure exemption in preparing these financial statements, as permitted by the FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland”. the requirements of Section 4 Statement of Financial Position paragraph 4.12 (a)(iv); the requirements of Section 7 Statement of Cash Flows; the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d); the requirements of Section 11 Financial Instruments paragraph 11.39 to 11.48 A; the requirements of Section 12 Other Financial Instruments paragraphs 12.26 to 12.29; the requirements of Section 33 Related Party Disclosures paragraph 33.7; the requirement to disclose effect of international tax reform-Pillar two model rules as required by paragraph 29.28(b), 29.29 of FRS 102. The information is included in the consolidated financial statements of the parent company, AIPCF VII DPC Funding LP which are available from the Companies House and from the Company at Maples Corporate Services Limited, P.O. Box 309, Ugland House, South Church Street, George Town, Grand Cayman KYI-1104, Cayman Islands. Foreign currencies The Company’s functional and presentational currency is the Euro. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated at the rate of exchange ruling at the balance sheet date. All differences are taken to the Profit and Loss Account. Interest income and expense Interest income or expense is recorded in the same Profit and Loss account in the period to which it relates. Interest income or expense is recognised using the effective interest method. The 'effective interest rate' is the rate that exactly discounts estimated future cash payments or receipts through the expected life of the financial instrument to: The gross carrying amount of the financial assets; or The amortised cost of the financial liability. Investments Investments are stated at cost less impairment. The carrying values of fixed asset investments are reviewed for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Debtors Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment for bad or doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad or doubtful debts Creditors Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method Financial instruments The Company has applied the Sections 11 and 12 of FRS 102 in respect of financial instruments. The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares. Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at the present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade payables or receivables, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like payment of a trade debt deferred beyond normal business terms or finance at a rate of interest that is not market rate or in case of an outright short term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost. Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If the objective evidence of impairment is found, an impairment loss is recognised in the statement of comprehensive income. For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset’s carrying amount and the present value of estimated cash flows discounted at the asset’s original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract. For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset’s carrying amount and best estimate of recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the balance sheet date. Financial assets and liabilities are offset and the net amount reported in the balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or realise the assets and settle the liability simultaneously Share capital Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as deduction, net of tax, from proceeds

ATTENDS HEALTHCARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

  • 2. Employees

    2024 2023
    Average number of employees during the period 0 0

ATTENDS HEALTHCARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

3. Debtors

2024 2023
£ £
Other debtors 41,000 38,000
Total 41,000 38,000

ATTENDS HEALTHCARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

4. Creditors: amounts falling due within one year note

2024 2023
£ £
Other creditors 259,000 235,000
Total 259,000 235,000